PTC Therapeutics
PTCT
PTCT
125 hedge funds and large institutions have $636M invested in PTC Therapeutics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
-4
Holders Change %
-3.1%
% of All Funds
2.84%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
24
Increased
42
Reduced
41
Closed
26
Calls
$9.17M
Puts
$48M
Net Calls
-$38.9M
Net Calls Change
+$6.04M
Top Buyers
| 1 |
SCM
1
Scopia Capital Management
New York
|
$69.1M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$45.4M |
| 3 |
RI
3
RTW Investments
New York
|
$68.9M |
| 4 |
4
Parallax Volatility Advisers
San Francisco,
California
|
$10.6M |
| 5 |
JGC
5
J. Goldman & Co
New York
|
$10.9M |
